FlexStone Enabled Kidney Stone Retrieval
1 other identifier
interventional
10
1 country
1
Brief Summary
This study investigates if additional basket control in helpful during retrieval of kidney stones especially those that are difficult to reach for standard baskets.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2024
CompletedStudy Start
First participant enrolled
March 8, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2024
CompletedOctober 31, 2024
October 1, 2024
8 months
March 8, 2024
October 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Successful retrieval of kidney stones
The primary end point of this feasibility study is to demonstrate that the additional basket aimability of the device enables basket to capture stones in difficult to reach locations such as the lower pole.
Day 1 Post-Intervention
Study Arms (1)
Kidney Stone Retrieval
EXPERIMENTALAll patients in this group will have the EndoTheia FlexStone basket used to assist in the retrieval of kidney stones
Interventions
Using FlexStone Basket aimability to retrieve kidney stones
Eligibility Criteria
You may qualify if:
- Male or female, 18 to 80 years of age
- Able to provide written informed consent
- Have renal stones present and are appropriate candidates for fURS
You may not qualify if:
- Females who are pregnant. As part of routine pre-operative care, all females of childbearing potential will undergo either urine or blood pregnancy testing.
- Cancer positive subjects or any patients currently undergoing any treatment or therapy to treat, cure, or mitigate cancer.
- Patients with active urinary tract infection or anatomy that complicates retrograde access to the ureter and kidney
- Patients who are unable or unwilling to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- EndoTheialead
- Vanderbilt University Medical Centercollaborator
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2024
First Posted
March 20, 2024
Study Start
March 8, 2024
Primary Completion
October 21, 2024
Study Completion
October 21, 2024
Last Updated
October 31, 2024
Record last verified: 2024-10